Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test scores may reveal heart attack risk

NCT ID NCT07369037

Knowledge-focused Sponsor: Muğla Sıtkı Koçman University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 1,000 people who had a severe type of heart attack (STEMI). Researchers checked two simple nutrition scores (CONUT and PNI) based on routine blood tests taken when patients arrived at the hospital. The goal was to see if these scores could predict who was more likely to die within two years. The study is already completed, and the results may help doctors identify high-risk patients early.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the scores prove useful, doctors might use simple blood tests to identify heart attack patients at higher risk, guiding more aggressive follow-up care.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove that improving nutrition changes outcomes, only that a link may exist. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,000 people

The number who actually took part.

Started

Jan 2022

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

A retrospective analysis of all major sequential calculations in 18 stages of past ST-elevation myocardial infarction (STEMI) diagnoses was planned. The analysis would examine disease-triggering factors, laboratory findings at admission, ECG and echocardiographic findings, as well as distribution, in-hospital, and long-term outcomes.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All patients over 18 years of age diagnosed with ST-elevation myocardial infarction (STEMI) treated percutaneously within the specified date range. Exclusion Criteria: * Patients under 18 years of age Patients for whom laboratory data is unavailable Patients with incomplete data Patients diagnosed with cancer Patients with hematological diseases Patients using glucocorticoid drugs Patients with liver disease Patients with kidney disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Conut score are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myocardial infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Conut score Mortality ST elevation (stemi) myocardial infarction

Contacts and locations

Locations

  • Mugla Sitki Kocman University

    Menteşe, Muğla, 48050, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.